IBDEI0HN ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,7946,1,3,0)
;;=3^Psoriasis NEC
;;^UTILITY(U,$J,358.3,7946,1,4,0)
;;=4^L40.8
;;^UTILITY(U,$J,358.3,7946,2)
;;=^271917
;;^UTILITY(U,$J,358.3,7947,0)
;;=L40.9^^39^391^294
;;^UTILITY(U,$J,358.3,7947,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7947,1,3,0)
;;=3^Psoriasis,Unspec
;;^UTILITY(U,$J,358.3,7947,1,4,0)
;;=4^L40.9
;;^UTILITY(U,$J,358.3,7947,2)
;;=^5009171
;;^UTILITY(U,$J,358.3,7948,0)
;;=L50.9^^39^391^326
;;^UTILITY(U,$J,358.3,7948,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7948,1,3,0)
;;=3^Urticaria,Unspec
;;^UTILITY(U,$J,358.3,7948,1,4,0)
;;=4^L50.9
;;^UTILITY(U,$J,358.3,7948,2)
;;=^5009204
;;^UTILITY(U,$J,358.3,7949,0)
;;=L53.8^^39^391^150
;;^UTILITY(U,$J,358.3,7949,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7949,1,3,0)
;;=3^Erythematous Conditions NEC
;;^UTILITY(U,$J,358.3,7949,1,4,0)
;;=4^L53.8
;;^UTILITY(U,$J,358.3,7949,2)
;;=^88044
;;^UTILITY(U,$J,358.3,7950,0)
;;=L53.9^^39^391^149
;;^UTILITY(U,$J,358.3,7950,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7950,1,3,0)
;;=3^Erythematous Condition,Unspec
;;^UTILITY(U,$J,358.3,7950,1,4,0)
;;=4^L53.9
;;^UTILITY(U,$J,358.3,7950,2)
;;=^5009210
;;^UTILITY(U,$J,358.3,7951,0)
;;=L54.^^39^391^148
;;^UTILITY(U,$J,358.3,7951,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7951,1,3,0)
;;=3^Erythema in Diseases Classified Elsewhere
;;^UTILITY(U,$J,358.3,7951,1,4,0)
;;=4^L54.
;;^UTILITY(U,$J,358.3,7951,2)
;;=^5009211
;;^UTILITY(U,$J,358.3,7952,0)
;;=L56.0^^39^391^142
;;^UTILITY(U,$J,358.3,7952,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7952,1,3,0)
;;=3^Drug Phototoxic Response
;;^UTILITY(U,$J,358.3,7952,1,4,0)
;;=4^L56.0
;;^UTILITY(U,$J,358.3,7952,2)
;;=^5009214
;;^UTILITY(U,$J,358.3,7953,0)
;;=L56.1^^39^391^141
;;^UTILITY(U,$J,358.3,7953,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7953,1,3,0)
;;=3^Drug Photoallergic Response
;;^UTILITY(U,$J,358.3,7953,1,4,0)
;;=4^L56.1
;;^UTILITY(U,$J,358.3,7953,2)
;;=^5009215
;;^UTILITY(U,$J,358.3,7954,0)
;;=L56.2^^39^391^274
;;^UTILITY(U,$J,358.3,7954,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7954,1,3,0)
;;=3^Photocontact Dermatitis
;;^UTILITY(U,$J,358.3,7954,1,4,0)
;;=4^L56.2
;;^UTILITY(U,$J,358.3,7954,2)
;;=^5009216
;;^UTILITY(U,$J,358.3,7955,0)
;;=L56.3^^39^391^308
;;^UTILITY(U,$J,358.3,7955,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7955,1,3,0)
;;=3^Solar Urticaria
;;^UTILITY(U,$J,358.3,7955,1,4,0)
;;=4^L56.3
;;^UTILITY(U,$J,358.3,7955,2)
;;=^5009217
;;^UTILITY(U,$J,358.3,7956,0)
;;=L57.0^^39^391^13
;;^UTILITY(U,$J,358.3,7956,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7956,1,3,0)
;;=3^Actinic Keratosis
;;^UTILITY(U,$J,358.3,7956,1,4,0)
;;=4^L57.0
;;^UTILITY(U,$J,358.3,7956,2)
;;=^66900
;;^UTILITY(U,$J,358.3,7957,0)
;;=L60.0^^39^391^164
;;^UTILITY(U,$J,358.3,7957,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7957,1,3,0)
;;=3^Ingrowing Nail
;;^UTILITY(U,$J,358.3,7957,1,4,0)
;;=4^L60.0
;;^UTILITY(U,$J,358.3,7957,2)
;;=^5009234
;;^UTILITY(U,$J,358.3,7958,0)
;;=L60.1^^39^391^272
;;^UTILITY(U,$J,358.3,7958,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7958,1,3,0)
;;=3^Onycholysis
;;^UTILITY(U,$J,358.3,7958,1,4,0)
;;=4^L60.1
;;^UTILITY(U,$J,358.3,7958,2)
;;=^186837
;;^UTILITY(U,$J,358.3,7959,0)
;;=L60.2^^39^391^271
;;^UTILITY(U,$J,358.3,7959,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7959,1,3,0)
;;=3^Onychogryphosis
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0HN 3790 printed Apr 09, 2024@20:58:13 Page 2
IBDEI0HN ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,7946,1,3,0)
+2 ;;=3^Psoriasis NEC
+3 ;;^UTILITY(U,$J,358.3,7946,1,4,0)
+4 ;;=4^L40.8
+5 ;;^UTILITY(U,$J,358.3,7946,2)
+6 ;;=^271917
+7 ;;^UTILITY(U,$J,358.3,7947,0)
+8 ;;=L40.9^^39^391^294
+9 ;;^UTILITY(U,$J,358.3,7947,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,7947,1,3,0)
+12 ;;=3^Psoriasis,Unspec
+13 ;;^UTILITY(U,$J,358.3,7947,1,4,0)
+14 ;;=4^L40.9
+15 ;;^UTILITY(U,$J,358.3,7947,2)
+16 ;;=^5009171
+17 ;;^UTILITY(U,$J,358.3,7948,0)
+18 ;;=L50.9^^39^391^326
+19 ;;^UTILITY(U,$J,358.3,7948,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,7948,1,3,0)
+22 ;;=3^Urticaria,Unspec
+23 ;;^UTILITY(U,$J,358.3,7948,1,4,0)
+24 ;;=4^L50.9
+25 ;;^UTILITY(U,$J,358.3,7948,2)
+26 ;;=^5009204
+27 ;;^UTILITY(U,$J,358.3,7949,0)
+28 ;;=L53.8^^39^391^150
+29 ;;^UTILITY(U,$J,358.3,7949,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,7949,1,3,0)
+32 ;;=3^Erythematous Conditions NEC
+33 ;;^UTILITY(U,$J,358.3,7949,1,4,0)
+34 ;;=4^L53.8
+35 ;;^UTILITY(U,$J,358.3,7949,2)
+36 ;;=^88044
+37 ;;^UTILITY(U,$J,358.3,7950,0)
+38 ;;=L53.9^^39^391^149
+39 ;;^UTILITY(U,$J,358.3,7950,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,7950,1,3,0)
+42 ;;=3^Erythematous Condition,Unspec
+43 ;;^UTILITY(U,$J,358.3,7950,1,4,0)
+44 ;;=4^L53.9
+45 ;;^UTILITY(U,$J,358.3,7950,2)
+46 ;;=^5009210
+47 ;;^UTILITY(U,$J,358.3,7951,0)
+48 ;;=L54.^^39^391^148
+49 ;;^UTILITY(U,$J,358.3,7951,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,7951,1,3,0)
+52 ;;=3^Erythema in Diseases Classified Elsewhere
+53 ;;^UTILITY(U,$J,358.3,7951,1,4,0)
+54 ;;=4^L54.
+55 ;;^UTILITY(U,$J,358.3,7951,2)
+56 ;;=^5009211
+57 ;;^UTILITY(U,$J,358.3,7952,0)
+58 ;;=L56.0^^39^391^142
+59 ;;^UTILITY(U,$J,358.3,7952,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,7952,1,3,0)
+62 ;;=3^Drug Phototoxic Response
+63 ;;^UTILITY(U,$J,358.3,7952,1,4,0)
+64 ;;=4^L56.0
+65 ;;^UTILITY(U,$J,358.3,7952,2)
+66 ;;=^5009214
+67 ;;^UTILITY(U,$J,358.3,7953,0)
+68 ;;=L56.1^^39^391^141
+69 ;;^UTILITY(U,$J,358.3,7953,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,7953,1,3,0)
+72 ;;=3^Drug Photoallergic Response
+73 ;;^UTILITY(U,$J,358.3,7953,1,4,0)
+74 ;;=4^L56.1
+75 ;;^UTILITY(U,$J,358.3,7953,2)
+76 ;;=^5009215
+77 ;;^UTILITY(U,$J,358.3,7954,0)
+78 ;;=L56.2^^39^391^274
+79 ;;^UTILITY(U,$J,358.3,7954,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,7954,1,3,0)
+82 ;;=3^Photocontact Dermatitis
+83 ;;^UTILITY(U,$J,358.3,7954,1,4,0)
+84 ;;=4^L56.2
+85 ;;^UTILITY(U,$J,358.3,7954,2)
+86 ;;=^5009216
+87 ;;^UTILITY(U,$J,358.3,7955,0)
+88 ;;=L56.3^^39^391^308
+89 ;;^UTILITY(U,$J,358.3,7955,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,7955,1,3,0)
+92 ;;=3^Solar Urticaria
+93 ;;^UTILITY(U,$J,358.3,7955,1,4,0)
+94 ;;=4^L56.3
+95 ;;^UTILITY(U,$J,358.3,7955,2)
+96 ;;=^5009217
+97 ;;^UTILITY(U,$J,358.3,7956,0)
+98 ;;=L57.0^^39^391^13
+99 ;;^UTILITY(U,$J,358.3,7956,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,7956,1,3,0)
+102 ;;=3^Actinic Keratosis
+103 ;;^UTILITY(U,$J,358.3,7956,1,4,0)
+104 ;;=4^L57.0
+105 ;;^UTILITY(U,$J,358.3,7956,2)
+106 ;;=^66900
+107 ;;^UTILITY(U,$J,358.3,7957,0)
+108 ;;=L60.0^^39^391^164
+109 ;;^UTILITY(U,$J,358.3,7957,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,7957,1,3,0)
+112 ;;=3^Ingrowing Nail
+113 ;;^UTILITY(U,$J,358.3,7957,1,4,0)
+114 ;;=4^L60.0
+115 ;;^UTILITY(U,$J,358.3,7957,2)
+116 ;;=^5009234
+117 ;;^UTILITY(U,$J,358.3,7958,0)
+118 ;;=L60.1^^39^391^272
+119 ;;^UTILITY(U,$J,358.3,7958,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,7958,1,3,0)
+122 ;;=3^Onycholysis
+123 ;;^UTILITY(U,$J,358.3,7958,1,4,0)
+124 ;;=4^L60.1
+125 ;;^UTILITY(U,$J,358.3,7958,2)
+126 ;;=^186837
+127 ;;^UTILITY(U,$J,358.3,7959,0)
+128 ;;=L60.2^^39^391^271
+129 ;;^UTILITY(U,$J,358.3,7959,1,0)
+130 ;;=^358.31IA^4^2
+131 ;;^UTILITY(U,$J,358.3,7959,1,3,0)
+132 ;;=3^Onychogryphosis
